Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah R Bulgart

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cells|June 28, 2023
Leveraging Plasma Membrane Repair Therapeutics for Treating Neurodegenerative DiseasesHannah R Bulgart, Isabella Goncalves, Noah Weisleder
Biomolecules|March 28, 2025
Enhancing Membrane Repair Using Recombinant MG53/TRIM72 (rhMG53) Reduces Neurotoxicity in Alzheimer's Disease ModelsHannah R Bulgart, Miguel A Lopez Perez, Noah Weisleder
Molecular Neurodegeneration|July 26, 2020
Microbial involvement in Alzheimer disease development and progressionHannah R Bulgart, Evan W Neczypor, Loren E Wold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentHannah R Bulgart, Miguel A Lopez Perez, Gianni N Giarrano, et al.
The Journal of General Physiology|May 14, 2026
Dysferlin's C2A domain supports normal Ca2+ signaling and membrane repair in dysferlin-null myofibersValeriy Lukyanenko, Joaquin Muriel, Kassidy K Banford, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 14, 2024
Plasma membrane repair defect in Alzheimer's disease neurons is driven by the reduced dysferlin expressionHannah R Bulgart, Miguel A Lopez Perez, Alexis Tucker, et al.
Molecular Therapy. Methods & Clinical Development|May 23, 2024
Nanodysferlins support membrane repair and binding to TRIM72/MG53 but do not localize to t-tubules or stabilize Ca<sup>2+</sup> signalingJoaquin Muriel, Valeriy Lukyanenko, Thomas A Kwiatkowski, et al.
Cells|May 14, 2022
Reduced Sarcolemmal Membrane Repair Exacerbates Striated Muscle Pathology in a Mouse Model of Duchenne Muscular DystrophyBrian J Paleo, Kevin E McElhanon, Hannah R Bulgart, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cells|June 28, 2023
Leveraging Plasma Membrane Repair Therapeutics for Treating Neurodegenerative DiseasesHannah R Bulgart, Isabella Goncalves, Noah Weisleder
Biomolecules|March 28, 2025
Enhancing Membrane Repair Using Recombinant MG53/TRIM72 (rhMG53) Reduces Neurotoxicity in Alzheimer's Disease ModelsHannah R Bulgart, Miguel A Lopez Perez, Noah Weisleder
Molecular Neurodegeneration|July 26, 2020
Microbial involvement in Alzheimer disease development and progressionHannah R Bulgart, Evan W Neczypor, Loren E Wold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentHannah R Bulgart, Miguel A Lopez Perez, Gianni N Giarrano, et al.
The Journal of General Physiology|May 14, 2026
Dysferlin's C2A domain supports normal Ca2+ signaling and membrane repair in dysferlin-null myofibersValeriy Lukyanenko, Joaquin Muriel, Kassidy K Banford, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 14, 2024
Plasma membrane repair defect in Alzheimer's disease neurons is driven by the reduced dysferlin expressionHannah R Bulgart, Miguel A Lopez Perez, Alexis Tucker, et al.
Molecular Therapy. Methods & Clinical Development|May 23, 2024
Nanodysferlins support membrane repair and binding to TRIM72/MG53 but do not localize to t-tubules or stabilize Ca<sup>2+</sup> signalingJoaquin Muriel, Valeriy Lukyanenko, Thomas A Kwiatkowski, et al.
Cells|May 14, 2022
Reduced Sarcolemmal Membrane Repair Exacerbates Striated Muscle Pathology in a Mouse Model of Duchenne Muscular DystrophyBrian J Paleo, Kevin E McElhanon, Hannah R Bulgart, et al.
Pageof 1